Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Case Series of Intraoperative Indocyanine Green Angiography Findings in Minimally Invasive Surgical Ligation of Cerebrospinal Fluid-Venous Fistulas.

Neurosurgery practice·2026

Same author

Brain-age defines a structural signature of outcomes after vagus nerve stimulation in children.

Brain stimulation·2026

Same author

Personalized Virtual Brain Simulations and Vagus Nerve Stimulation Outcomes in Pediatric Epilepsy: A Multicenter Study From the CONNECTiVOS Collaboration.

Neuromodulation : journal of the International Neuromodulation Society·2026

Same author

PRMT5 inhibition impairs Fanconi Anemia pathway-mediated homologous recombination and enhances the antitumor efficacy of Temozolomide in glioblastoma.

Cell death & disease·2026

Same author

A deep representation learning model to predict response to vagus nerve stimulation.

Nature communications·2026

Same author

Society for Pediatric Neurosurgical Oncology: why now is the time.

Journal of neurosurgery. Pediatrics·2026

Search research articles

Related Experiment Video

Updated: Oct 31, 2025

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Carotid Body Tumor Microenvironment.

Jean-Paul Bryant¹, Shelly Wang^1,2, Toba Niazi^3,4

¹Miller School of Medicine, University of Miami, Miami, FL, USA.

Advances in Experimental Medicine and Biology

|June 29, 2021

Summary

This summary is machine-generated.

Carotid body tumors (CBTs) are rare head and neck paragangliomas. Diagnosis involves physical exam, imaging, and biochemical tests, with management including surgical resection or embolization.

Keywords:

Angiogenesis Carotid artery Carotid body Chemodectoma Endocrine Multiple endocrine neoplasia Neck Neuroendocrine Neuroncology Neurosurgery Oncology Paraganglioma Resection Surgery Tumor

More Related Videos

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Published on: February 8, 2017

A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication

A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication

Published on: September 20, 2016

Related Experiment Videos

Last Updated: Oct 31, 2025

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Published on: February 8, 2017

A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication

A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication

Published on: September 20, 2016

Area of Science:

Oncology
Head and Neck Surgery
Endocrinology

Background:

Carotid body tumors (CBTs) are rare paragangliomas, representing 0.5% of head and neck tumors.
CBTs typically arise at the carotid bifurcation, often presenting as asymptomatic, unilateral masses.
While most CBTs are sporadic, 15% are linked to familial syndromes or chronic hypoxia.

Purpose of the Study:

To provide a comprehensive overview of carotid body tumors.
To detail the diagnostic workup for CBTs.
To discuss current management strategies for CBTs.

Main Methods:

Review of clinical presentation and diagnostic modalities for CBTs.
Discussion of surgical and interventional radiological management options.
Analysis of tumor characteristics and patient outcomes.

Main Results:

CBTs often present asymptomatically, leading to delayed diagnosis.
Diagnostic workup includes physical examination, imaging (e.g., CT, MRI), vascular studies, and biochemical analysis (24-hour urinary catecholamines/metanephrines).
Management strategies vary based on tumor size and vascularity, including surgical resection and embolization.

Conclusions:

Early diagnosis and appropriate management are crucial for CBTs.
Multidisciplinary approach involving surgeons, radiologists, and endocrinologists optimizes patient care.
Further research into the genetic and environmental factors influencing CBT development is warranted.